Migromin (Paracetamol, Acetylsalicylic Acid, Caffeine)

Paracetamol reduces central prostaglandin production, lowering pain and fever. Acetylsalicylic acid irreversibly inhibits COX‑1 and COX‑2, decreasing peripheral prostaglandins and platelet aggregation. Caffeine blocks adenosine receptors, enhancing the analgesic effect and counteracting drowsiness, resulting in a synergistic relief of pain and fever.

The appropriate dose of Migromin is determined by the prescribing healthcare professional based on the patient’s age, weight, clinical condition and any concomitant medications. Patients should follow the prescriber’s instructions and not exceed the recommended amount.

Safety data for Migromin in pregnancy and lactation are limited. Paracetamol is generally considered low risk, but acetylsalicylic acid and caffeine may pose risks to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should consult their physician before using Migromin.

To order Migromin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Migromin offers a non‑prescription option that combines analgesic, anti‑inflammatory and stimulant effects, suitable for mild to moderate migraine attacks. Prescription triptans target serotonin receptors and are often more effective for severe migraines, but they require medical supervision. Migromin may be preferred for early‑stage attacks or when triptans are contraindicated.

Migromin tablets should be stored at ambient temperature, below 25 °C. Keep them in the original packaging, protect from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Migromin is taken orally with a full glass of water. It can be taken with or without food, although taking it with food may reduce stomach irritation. The tablet should be swallowed whole and not chewed or crushed.

Serious risks include gastrointestinal bleeding or ulceration, severe allergic reactions such as anaphylaxis, liver injury reflected by elevated enzymes, and renal impairment. Patients experiencing unusual bleeding, rash, jaundice, or sudden kidney problems should seek medical attention promptly.

Migromin should be avoided in individuals with known hypersensitivity to paracetamol, aspirin or caffeine, those with active peptic ulcer disease, uncontrolled bleeding disorders, severe liver or kidney disease, and in children under the age recommended by local regulations. Pregnant women should consult a physician before use.